Est. 2013 (announced 2012), wholly govt-owned development bank. £25.6bn total financial capacity; £4.7bn investment portfolio (£3.2bn equity, £1.5bn debt); 2024/25 supported £6.8bn finance. Largest LP in UK VC/growth capital funds. Subsidiaries: British Patient Capital, British Business Investments. Team c.150+. Value-add: market intelligence (equity tracker, regional tracker), emerging manager support, crowd-in capital model (£801m ECF crowd-in, £8bn BPC crowd-in). Sheffield HQ.
Investment Focus
Investment Thesis
Seed to growth stage. Cornerstone LP via £2.5bn equity programme investing in VC/venture growth funds & direct co-investment. Subsidiary programmes: British Patient Capital (£1.4bn committed, pari passu basis), British Business Investments (Regional Angels, Managed Funds). Programmes: ECF (£1.1bn committed), Future Fund, Angel CoFund, regional funds (North/Midlands/Scotland/Wales/NI). Avoids direct lending to most firms; works through accredited partners. Focus: UK SMEs, deeptech, life sciences, defence, emerging managers.
Interested in connecting?
Visit their website or reach out directly.